Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
6
×
national blog main
national top stories
new york blog main
new york top stories
praluent
6
×
regeneron pharmaceuticals
san francisco blog main
san francisco top stories
amgen
biotech
boulder/denver blog main
boulder/denver top stories
cholesterol
detroit blog main
detroit top stories
inclisiran
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
repatha
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
pcsk9
sanofi
data
fda
ldl
medco
What
cholesterol
bio
drug
healthcare
lowering
roundup
medco
medicines
twice
week
abbvie’s
aces
america
american
announced
barbecuing
based
best
big
biogen
bringing
camping
cardiologist
center
ceo
check
clears
closer
conference
continue
continues
convoluted
crash
day
debate
democrats
dreams
drugs
expensive
faces
Language
unset
Current search:
praluent
×
" life sciences "
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More